Skip to main navigation Skip to search Skip to main content

Current view from alzheimer disease to type 2 diabetes mellitus

  • Mahmood Rasool
  • , Arif Malik
  • , Aamer M. Qazi
  • , Ishfaq A. Sheikh
  • , Abdul Manan
  • , Sumaira Shaheen
  • , Mahmood H. Qazi
  • , Adeel G. Chaudhary
  • , Adel M. Abuzenadah
  • , Muhammad Asif
  • , Mohammed H. Alqahtani
  • , Zafar Iqbal
  • , Munvar M. Shaik
  • , Siew H. Gan
  • , Mohammad A. Kamal

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that leads to memory problems. It has been associated with type 2 diabetes mellitus at both the molecular and biochemical level. Pancreatic cells have molecular similarities to the brain at the transcriptomic and proteomic levels. Several genes have been reported to be responsible for both AD and diabetes. Currently, no proper treatment is available but various therapeutic approaches are utilized worldwide for the management of these disorders and may be nanoparticles and herbal treatment of Bacopa monnieri will make promise for the treatment of AD in future. The formation of amyloids in neurons and the formation of amylin in pancreatic cells are potential links between these two disorders, which can be silent killers.

Original languageEnglish
Pages (from-to)533-542
Number of pages10
JournalCNS & Neurological Disorders - Drug Targets
Volume13
Issue number3
DOIs
Publication statusPublished - 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amyloid
  • Neurodegenerative
  • Pancreatic cells
  • Type 2 diabetes mellitus

Cite this